A protein that stops cells from dividing in response to damage or stress could be a new biomarker or therapeutic target for ...

India faces a growing liver disease crisis linked to obesity and diabetes, affecting even non-drinkers. Experts warn that ...

Unlike liver disease linked to alcohol abuse, MASLD is driven largely by metabolic imbalances, poor diet and sedentary ...

MASLD, previously called ‘fatty liver disease’, is a ticking timebomb, affecting 30 to 40 per cent of adults – most of whom ...

The researchers analyzed gene and protein expression, along with lipid profiles, in the bone marrow of mice whose Elovl2 gene ...

An international team of microbiologists from the Medical University of Graz, the DSMZ—German Collection of Microorganisms ...

It's estimated that around one in every three adults have metabolic syndrome in the US. Although it only gained formal medical recognition in 1998, it's fast becoming one of the most prevalent health ...

Recent advances have marked a turning point for the treatment noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), with more therapies on the horizon to hopefully better address ...

89bio, Inc. is a clinical-stage biotech focused on liver and cardio-metabolic diseases, with its lead drug candidate ...

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) and published in The Journal of Internal Medicine shows that, in survivors of breast ...

New research presented at the European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) and published in The Journal ...

April 15, 2025 - Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on ...